Showing results (171-180 of 241) with videos related to
Sort By:
Pageof 25
Gynecologic Oncology|September 30, 2022
High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancerElizabeth Buckley, Mary M Mullen, Rehan A Nizamuddin, et al.Gynecologic Oncology|December 29, 2016
A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group studyCarolyn K McCourt, Wei Deng, Don S Dizon, et al.Gynecologic Oncology Reports|January 13, 2022
Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology careShaina F Bruce, Bridget Huysman, Jinai Bharucha, et al.Cancer|January 30, 2024
Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti-PD-L1, for BRCA wild-type, platinum-sensitive, recurrent ovarian cancerDavid Mutch, Athina Voulgari, Xian Marissa Chen, et al.Gynecologic Oncology|May 27, 2022
Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planningAngela C Nolin, Chunqiao Tian, Chad A Hamilton, et al.Gynecologic Oncology|June 18, 2021
Text-message-based behavioral weight loss for endometrial cancer survivors with obesity: A randomized controlled trialAbigail S Zamorano, Elise M Wilson, Jingxia Liu, et al.Gynecologic Oncology|September 16, 2022
HER2 in Uterine Serous Carcinoma: Testing platforms and implications for targeted therapyTenley R Klc, Sharon Wu, Annelise M Wilhite, et al.Gynecologic Oncology|July 10, 2020
Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group studyWarner K Huh, William E Brady, Paula M Fracasso, et al.Cancer Research|July 22, 2025
Multi-omic Characterization of Pre- and Post-neoadjuvant Chemotherapy Treated Ovarian Cancer Reveals Mediators of Tumorigenesis and Chemotherapy ResponseMark C Valentine, Mary M Mullen, Emilee N Kotnik, et al.Gynecologic Oncology|February 26, 2019
Continuous epidural infusion in gynecologic oncology patients undergoing exploratory laparotomy: The new standard for decreased postoperative pain and opioid useSarah P Huepenbecker, Sarah E Cusworth, Lindsay M Kuroki, et al.Pageof 25